Bushido Capital US Equity ETF
SMRI

$30.49

0.26%

Market Cap: $372M

0

Funds holding %

of 6,728 funds

–

Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

50% more funds holding

Funds holding: 2 [Q1] → 3 (+1) [Q2]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q1] → 1 (+0) [Q2]

10.32% less ownership

Funds ownership: 53.54% [Q1] → 43.22% (-10.32%) [Q2]

20% less capital invested

Capital invested by funds: $183M [Q1] → $146M (-$37.1M) [Q2]

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for SMRI.

See Analyst Rankings

Financial journalist opinion

SMRI: Don't Jump The Gun Based On The Fed's Interest Rate Decision Today

The Bushido Capital US Equity ETF is currently too expensive and not well-positioned for a potential economic downturn, especially given its low allocation to resilient sectors like consumer staples and utilities. SMRI is heavily weighted towards healthcare and consumer cyclical sectors, which may benefit from falling interest rates, but it's too early to rotate into value stocks. The Fed's interest rate cuts are uncertain and may not lead to rapid declines, making it premature to invest in this ETF for short-term gains.

SMRI: Don't Jump The Gun Based On The Fed's Interest Rate Decision Today

CNBC Television

The return of value investing ETFs

CNBC's Bob Pisani sits down with KraneShares chief investment officer Brendan Ahern and Sepio Capital co-CIO and managing director John Beatson to discuss the rise of value investing ETFs and the philosophy behind Sepio Capital's strategy.

The return of value investing ETFs

See News Rankings